Can GLP-1 medication reduce the risk of Alzheimer’s Disease?
GLP-1 receptor agonists such as Semeglutide (Ozempic® and Wegovy®) are becoming a household name for weight-loss treatments for clinically obese patients, with 82% of adults having heard about GLP-1 medications. However, the benefits of GLP-1 medications are not just limited to
Is the term ‘obese’ outdated? New global report says yes!
With the huge success of the once-weekly injectable weight-loss treatments such as Ozempic® and Wegovy® over recent years to help combat the global ‘obesity’ epidemic; medical professionals have called for a new definition of the term ‘obese’. Despite individuals with higher
QuickDoc’s Quick Chats Travel Medicine
Malaria is a life-threating disease caused by parasites which are spread to humans through the bites of infected mosquitos and the release of malaria sporozites. The sporozite then travels to the liver invading liver cells. Once matured in the liver,